Trimble
TRIMBLE INC.
Key figures
Period 2025-01-04 to 2026-01-02ConsolidatedU.S. GAAP
RevenueDisclosed
US$3.6B
Operating marginCalculated
16.5%
Net assets to total assetsCalculated
62.7%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★★★☆position among all companies
16.5%
Growth (revenue, 4-year average)
★☆☆☆☆position among all companies
-0.5%
Capital efficiency
★★☆☆☆position among all companies
7.3%
Revenue and profit
Performance, financial position and capital allocation
Trimble
Recent performance trends
Trimble
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$3.7 billion | US$3.7 billion | US$3.8 billion | US$3.7 billion | US$3.6 billion |
| Operating income | US$0.6 billion | US$0.5 billion | US$0.4 billion | US$0.5 billion | US$0.6 billion |
| Net income | US$0.5 billion | US$0.4 billion | US$0.3 billion | US$1.5 billion | US$0.4 billion |
| Total assets | US$7.1 billion | US$7.3 billion | US$9.5 billion | US$9.5 billion | US$9.3 billion |
| Shareholders' equity | US$3.9 billion | US$4.1 billion | US$4.5 billion | US$5.7 billion | US$5.8 billion |
| Net cash provided by (used in) operating activities | US$0.8 billion | US$0.4 billion | US$0.6 billion | US$0.5 billion | US$0.4 billion |
| Net cash provided by (used in) investing activities | US$-0.2 billion | US$-0.2 billion | US$-2.1 billion | US$1.9 billion | US$-37.00 million |
| Net cash provided by (used in) financing activities | US$-0.4 billion | US$-0.2 billion | US$1.4 billion | US$-1.9 billion | US$-0.9 billion |
| Cash and cash equivalents | US$0.3 billion | US$0.3 billion | US$0.2 billion | US$0.7 billion | US$0.3 billion |
Revenue scale in the same industry
Trimble
Instruments and medical devices: 43 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 Thermo Fisher ScientificFY Dec 2025 US$44.6B
- 2 Northrop Grumman Corp /DE/FY Dec 2025 US$42.0B
- 3 MedtronicFY Apr 2026 US$36.4B
- … 33 companies
- 37 Dentsply SironaFY Dec 2025 US$3.7B
- 38 Leonardo DRSFY Dec 2025 US$3.6B
- 39 TrimbleThis companyFY Jan 2026 US$3.6B
- 40 BrukerFY Dec 2025 US$3.4B
- 41 TeradyneFY Dec 2025 US$3.2B
- … 2 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$25.30 million | Consolidated | Disclosed |
| Cash and cash equivalents | US$0.3 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-0.9 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-37.00 million | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.4 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.2 billion | Consolidated | Disclosed |
| Net assets | US$5.8 billion | Consolidated | Disclosed |
| Net sales | US$3.6 billion | Consolidated | Disclosed |
| Operating income | US$0.6 billion | Consolidated | Disclosed |
| Net income | US$0.4 billion | Consolidated | Disclosed |
| Total assets | US$9.3 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$0.9 billion | Consolidated | Disclosed |
| Operating margin | 16.5% | Consolidated | Calculated |
| Net assets to total assets | 62.7% | Consolidated | Calculated |
| Net margin | 11.8% | Consolidated | Calculated |
| Return on equity | 7.3% | Consolidated | Calculated |